94503-0
SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
Active
94768-9 SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Term Description
Qualitative detection of IgA antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgA
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69 (MIN)
- Order vs. Observation
- Observation
Example Answer List LL3713-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 | ||
| Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value) | LA11885-3 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | SARS-CoV-2 (COVID-19) IgA: |
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgA: |
| el-GR | Greek (Greece) | Κορωνοϊός SARS 2 Αντισώματα IgA: Synonyms: IA IA.rapid MICRO Ord PrThr Pt Αίμα Ανοσοσφαιρίνη Α Αντίσωμα Αντισώματα IgA Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ορός Ορός/Πλάσμα Ορός/Πλάσμα/Αίμα Πλάσμα Πλάσμα/Αίμα |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgA: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgA: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgA: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgA: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgA: Synonyms: anticorpi anti-IgA anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgA: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgA: Synonyms: Immunoglobulina A Koronawirus osocze lub krew Przeciwciała do SARS-CoV-2; |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgA: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
94508-9 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Term Description
Qualitative detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgM
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69 (MIN)
- Order vs. Observation
- Both
Example Answer List LL4623-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
| Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
| Suspected | LA15291-0 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | SARS-CoV-2 (COVID-19) IgM: |
| de-AT | German (Austria) | Synonyms: SARS-CoV-2-AK IgM ql. |
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgM: |
| el-GR | Greek (Greece) | Κορωνοϊός SARS 2 Αντισώματα IgM: Synonyms: IA IA.rapid MICRO Ord PrThr Pt Αίμα Ανοσοσφαιρίνη M Αντίσωμα Αντισώματα IgM Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ορός Ορός/Πλάσμα Ορός/Πλάσμα/Αίμα Πλάσμα Πλάσμα/Αίμα |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgM: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgM: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgM: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgM: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgM: Synonyms: Anticorpi IgM anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgM: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgM: Synonyms: IgM Koronawirus osocze lub krew Przeciwciała do SARS-CoV-2; |
| uk-UA | Ukrainian (Ukraine) | SARS коронавірус 2 Антитіла.IgM: Synonyms: 2019 Novel Coronavirus; |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgM: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
94507-1 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Term Description
Qualitative detection of IgG antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgG
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 793
Example Answer List LL4623-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
| Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
| Suspected | LA15291-0 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | SARS-CoV-2 (COVID-19) IgG: |
| de-AT | German (Austria) | Synonyms: SARS-CoV-2-AK IgG ST |
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgG: |
| el-GR | Greek (Greece) | Κορωνοϊός SARS 2 Αντισώματα IgG: Synonyms: IA IA.rapid MICRO Ord PrThr Pt Αίμα Ανοσοσφαιρίνη G Αντίσωμα Αντισώματα IgG Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ορός Ορός/Πλάσμα Ορός/Πλάσμα/Αίμα Πλάσμα Πλάσμα/Αίμα |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgG: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgG: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgG: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgG: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgG: Synonyms: anticorpi IgG anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgG: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgG: Synonyms: IgG Koronawirus osocze lub krew Przeciwciała do SARS-CoV-2; |
| uk-UA | Ukrainian (Ukraine) | SARS коронавірус 2 Антитіла.IgG: Synonyms: 2019 Novel Coronavirus; |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgG: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
95542-7 SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Term Description
Qualitative detection of Total antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. This test detects but does not differentiate between antibody isotypes. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.70 (NAM)
- Change Reason
- Release 2.70: COMPONENT: Correct component is total antibody; DefinitionDescription: Corrected to reflect non-isotype specificity.;
- Order vs. Observation
- Both
Example Answer List LL3713-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 | ||
| Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value) | LA11885-3 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | SARS-CoV-2 (COVID-19) Ab: |
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak: |
| el-GR | Greek (Greece) | Κορωνοϊός SARS 2 Αντίσωμα: Synonyms: IA IA.rapid MICRO Ord PrThr Pt Αίμα Αντίσωμα Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ορός Ορός/Πλάσμα Ορός/Πλάσμα/Αίμα Πλάσμα Πλάσμα/Αίμα |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) Anticuerpos: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgG + IgM: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, Ac: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab: Synonyms: anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab: Synonyms: Koronawirus osocze lub krew Przeciwciała do SARS-CoV-2; |
| uk-UA | Ukrainian (Ukraine) | SARS коронавірус 2 Антитіла: Synonyms: 2019 Novel Coronavirus; |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.